The RSV vaccine is free in Australia for specific eligible groups under the National Immunisation Program. It is not free for every Australian. Eligibility depends on age, pregnancy status, and whether you are Aboriginal or Torres Strait Islander.
This guide explains who qualifies for free RSV protection in 2026, how infant protection works, who may need to pay, and what to ask your GP before booking.
Key Takeaways
- The RSV vaccine is free in Australia for specific eligible groups under the National Immunisation Program (NIP).
- Pregnant women between 28 and 36 weeks may receive a free RSV vaccine during each pregnancy.
- Adults aged 75 years and over may qualify for free RSV vaccination under current 2026 eligibility rules.
- Aboriginal and Torres Strait Islander adults aged 60 years and over may also be eligible under the NIP.
- Babies do not receive an RSV vaccine, but eligible infants may access nirsevimab (Beyfortus) through separate state-funded programs.
- Adults outside funded groups may need to discuss private vaccination options with their GP.
- Checking current eligibility with your GP before booking is the safest way to confirm available options.
Who Can Get a Free RSV Vaccine Under the NIP?
The Australian Government Department of Health confirms the following eligibility groups under the National Immunisation Program (NIP) in 2026:
| Eligible Group | Free Under NIP? | Key Detail |
| Pregnant women 28 to 36 weeks | Yes | Abrysvo, funded each pregnancy |
| Adults aged 75 and over | Yes | Arexvy, single dose, from 15 May 2026 |
| Aboriginal and Torres Strait Islander adults aged 60 and over | Yes | Arexvy, single dose, from 15 May 2026 |
| Other adults aged 60 to 74 | Generally no | May consider private vaccination |
| Eligible infants | Different program | May receive nirsevimab, not a vaccine |
The National Centre for Immunisation Research and Surveillance confirms that RSV immunisation products are not currently funded for adults outside these NIP categories.
Is the RSV Vaccine Free During Pregnancy?
Yes. The maternal RSV vaccine Abrysvo is free under the NIP for pregnant women from 28 to 36 weeks of pregnancy. It is recommended during each pregnancy.
When a pregnant woman receives Abrysvo, antibodies transfer through the placenta to help protect the baby against RSV after birth. The Department of Health notes that this form of passive immunisation may help provide protection for the infant during the early months after birth. Your GP or midwife can confirm timing and suitability based on your individual pregnancy.
Are Babies Eligible for a Free RSV Vaccine?
Babies do not receive the maternal RSV vaccine. The products Abrysvo and Arexvy are not approved for use in infants or children.
Eligible babies may instead receive nirsevimab, also known as Beyfortus. This is a long-acting monoclonal antibody, not a vaccine. According to Better Health Channel Victoria, infants from birth to eight months may be eligible if:
- Their mother did not receive the RSV vaccine during pregnancy
- Their mother was vaccinated less than two weeks before birth
- They have medical conditions associated with an increased risk of severe RSV disease
State and territory programs fund nirsevimab for eligible infants. Availability, program dates, and eligibility rules may vary by state. Parents should confirm current details with their GP or children’s health provider.
Who May Need to Pay for RSV Vaccination?
Adults aged 60 to 74 who are not Aboriginal or Torres Strait Islander are not currently funded under the NIP. The NCIRS notes that these adults may still consider vaccination based on age and medical risk factors, but this would generally require private purchase.
Adults with chronic respiratory conditions, heart disease, or weakened immune systems who fall outside funded age groups may also wish to discuss vaccination with their GP. Private RSV vaccination costs may vary depending on the provider and consultation requirements. Check consultation fees with your clinic to understand what costs may apply.
Why RSV Protection Matters for Higher-Risk Groups
Respiratory syncytial virus is a common virus that can cause more serious illness in some people. Groups at higher risk of complications include:
- Babies under 12 months, especially premature infants
- Older adults, particularly those aged 75 and over
- Pregnant women, due to the potential risk to the newborn
- People with chronic lung disease, heart disease, or COPD
- Immunocompromised patients
The Australian Government reports that RSV hospitalisation rates are highest among adults aged 75 and over and infants under 12 months. This is one reason current immunisation programs prioritise these higher-risk groups.
How to Check Your RSV Vaccine Eligibility Before Booking
Before arranging an RSV vaccination appointment, confirm:
- Your age and whether you fall within an NIP-funded group
- Your pregnancy stage, if relevant
- Your Aboriginal or Torres Strait Islander status for age-based eligibility
- Whether your infant may qualify for a state-funded program
- Whether your GP or provider currently stocks the correct RSV product
- Whether any consultation or administration fee applies
- Your Medicare card details
If you are unsure whether you qualify for free RSV vaccination, contact Clarence Town Healthcare to check current eligibility and appointment availability.
RSV Vaccine and Other Winter Vaccinations
RSV vaccination is one of several immunisation options available before winter. Patients may wish to discuss timing with their GP, particularly if they are also due for an influenza vaccination or other seasonal immunisation.
Your GP can advise whether multiple vaccinations can be given at the same visit or whether separate appointments are more appropriate based on your health history and current guidelines.
FAQs
Is the RSV vaccine free for everyone in Australia?
No. It is free under the NIP only for specific eligible groups: pregnant women at 28 to 36 weeks, adults aged 75 and over, and Aboriginal and Torres Strait Islander adults aged 60 and over.
Is the RSV vaccine free for pregnant women?
Yes. Abrysvo is NIP-funded for pregnant women from 28 to 36 weeks of pregnancy and is recommended during each pregnancy.
Can babies get the RSV vaccine?
Babies do not receive an RSV vaccine. Eligible infants may receive nirsevimab (Beyfortus), a long-acting monoclonal antibody funded through state and territory programs.
Is the RSV vaccine free for older adults?
Yes, for adults aged 75 and over and Aboriginal and Torres Strait Islander adults aged 60 and over. Funding through the NIP began on 15 May 2026.
Should I ask my GP before getting RSV vaccination?
Yes. A GP can confirm eligibility, timing, medical suitability, and current vaccine availability before you book.